ClinicalTrials.Veeva

Menu
D

DaVita Clinical Research DCT RDN | InterMed Consultants, Ltd.

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

VX-147
BION-1301
Finerenone
Zanubrutinib
KBP-5074

Parent organization

This site is a part of DaVita Clinical Research DCT RDN

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials
Locations recently updated

A Study of BION-1301 in Adults With IgA Nephropathy

Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy

Enrolling
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: BION-1301
Locations recently updated

The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to e...

Enrolling
Primary Membranous Nephropathy
Drug: Tacrolimus
Drug: Zanubrutinib

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

Trial sponsors

Bayer logo
BeiGene logo
C
K
Vertex Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems